rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Gregory Russotti

Officer

Company insider

Files Form 4 as: Chief Technology Officer, Century Therapeutics.

In numbers

Trades disclosed
36
Buys
0
Sells
18
Bought
$0
Sold
$163K
Companies
1
Companies where not an officer
0
First trade
25 Jan 2022
Last trade
14 Sep 2026
Last filed
15 Sep 2026

Companies traded

Where they are an officer
IPSC Century TherapeuticsOfficer · Biotechnology · last 14 Sep 20260 buys · 18 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
14 Sep 2026filed 15 Sep 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$4,9932,587 at $1.93filing
14 Sep 2026filed 15 Sep 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$4,9932,587 at $1.93filing
8 Sep 2026filed 9 Sep 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$1,095534 at $2.05filing
8 Sep 2026filed 9 Sep 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$1,095534 at $2.05filing
12 Jun 2026filed 15 Jun 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$5,7672,584 at $2.23filing
12 Jun 2026filed 15 Jun 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$5,7622,584 at $2.23filing
8 Jun 2026filed 9 Jun 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$1,106524 at $2.11filing
8 Jun 2026filed 9 Jun 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$1,106524 at $2.11filing
12 Mar 2026filed 16 Mar 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$26K10,076 at $2.55filing
12 Mar 2026filed 16 Mar 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$26K10,076 at $2.55filing
9 Mar 2026filed 11 Mar 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$1,215479 at $2.54filing
9 Mar 2026filed 11 Mar 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$1,217479 at $2.54filing
2 Feb 2026filed 4 Feb 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Code A—135,000 at $0.00filing
2 Feb 2026filed 4 Feb 2026IPSC Century Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—265,000 at $0.00filing
2 Feb 2026filed 4 Feb 2026IPSC Century Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—265,000 at $0.00filing
2 Feb 2026filed 4 Feb 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Code A—135,000 at $0.00filing
8 Dec 2025filed 10 Dec 2025IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$279526 at $0.53filing
8 Sep 2025filed 10 Sep 2025IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$270539 at $0.50filing
9 Jun 2025filed 11 Jun 2025IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$326526 at $0.62filing
11 Mar 2025filed 12 Mar 2025IPSC Century Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—120,000 at $0.00filing

Sectors

Health Care18

Buys in green, sells in red, by the company’s sector.

Related people

Douglas CarrSVP Finance & Operations · SVP Finance & Operations at Century Therapeutics, filing Form 4 there in the last year
Brent PfeiffenbergerPresident and CEO · President and CEO at Century Therapeutics, filing Form 4 there in the last year
Joseph TruittDirector · Director at Century Therapeutics, filing Form 4 there in the last year
Chad CowanChief Scientific Officer · Chief Scientific Officer at Century Therapeutics, filing Form 4 there in the last year
Alessandro RivaDirector · Director at Century Therapeutics, filing Form 4 there in the last year